These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 26724146)

  • 1. The Petersen prognostic index revisited in Dukes B colon cancer--Inter-institutional differences.
    Cserni G; Bori R; Sejben I; Ágoston EI; Ács B; Szász AM
    Pathol Res Pract; 2016 Feb; 212(2):73-6. PubMed ID: 26724146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Petersen Index score for Dukes'B colorectal cancer in a population of 103 consecutive resected patients.
    Cerullo G; Cassini D; Baldazzi G
    Updates Surg; 2012 Jun; 64(2):95-9. PubMed ID: 22460519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer.
    Roxburgh CS; Crozier JE; Maxwell F; Foulis AK; Brown J; McKee RF; Anderson JH; Horgan PG; McMillan DC
    Br J Cancer; 2009 Mar; 100(5):701-6. PubMed ID: 19209171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer.
    Petersen VC; Baxter KJ; Love SB; Shepherd NA
    Gut; 2002 Jul; 51(1):65-9. PubMed ID: 12077094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study.
    Allegra CJ; Paik S; Colangelo LH; Parr AL; Kirsch I; Kim G; Klein P; Johnston PG; Wolmark N; Wieand HS
    J Clin Oncol; 2003 Jan; 21(2):241-50. PubMed ID: 12525515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for survival after curative resection of Dukes' B colonic cancer.
    Saha AK; Smith KJ; Sue-Ling H; Sagar PM; Burke D; Finan PJ
    Colorectal Dis; 2011 Dec; 13(12):1390-4. PubMed ID: 21073647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.
    Wang Y; Jatkoe T; Zhang Y; Mutch MG; Talantov D; Jiang J; McLeod HL; Atkins D
    J Clin Oncol; 2004 May; 22(9):1564-71. PubMed ID: 15051756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
    Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
    Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oncological outcome after right hemicolectomy and accuracy of CT scan as a preoperative tool for staging in right sided colonic cancers.
    Lim M; Hussain Z; Howe A; Storey R; Petty D; Haselden J; Sebag-Montefiore D; Alexander D
    Colorectal Dis; 2013 May; 15(5):536-43. PubMed ID: 23067005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancer.
    Peng SL; Thomas M; Ruszkiewicz A; Hunter A; Lawrence M; Moore J
    ANZ J Surg; 2014 Nov; 84(11):837-41. PubMed ID: 24224835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour budding is a reproducible index for risk stratification of patients with stage II colon cancer.
    Lai YH; Wu LC; Li PS; Wu WH; Yang SB; Xia P; He XX; Xiao LB
    Colorectal Dis; 2014 Apr; 16(4):259-64. PubMed ID: 24118729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of MVD, LVD and vascular invasion in lymph node-negative colon cancer.
    Sundov Z; Tomic S; Alfirevic S; Sundov A; Capkun V; Nincevic Z; Nincevic J; Kunac N; Kontic M; Poljak N; Druzijanic N
    Hepatogastroenterology; 2013 May; 60(123):432-8. PubMed ID: 23321007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
    Yun HR; Kim HC; Yun SH; Lee WY
    Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pT4 stage II and III colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd's local peritoneal involvement revisited.
    Snaebjornsson P; Coupe VM; Jonasson L; Meijer GA; van Grieken NC; Jonasson JG
    Int J Cancer; 2014 Jul; 135(2):467-78. PubMed ID: 24347179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer.
    Allegra CJ; Parr AL; Wold LE; Mahoney MR; Sargent DJ; Johnston P; Klein P; Behan K; O'Connell MJ; Levitt R; Kugler JW; Tria Tirona M; Goldberg RM
    J Clin Oncol; 2002 Apr; 20(7):1735-43. PubMed ID: 11919229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin D is an independent prognostic marker for survival in stage IIB-IIC colon cancer patients treated with 5-fluoruracil-based adjuvant chemotherapy.
    Zhao S; Jiang T; Tang H; Cui F; Liu C; Guo F; Lu H; Xue Y; Jiang W; Peng Z; Yan D
    J Gastroenterol Hepatol; 2015 Apr; 30(4):680-8. PubMed ID: 25238407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer.
    Cakar B; Varol U; Junushova B; Muslu U; Gursoy Oner P; Gokhan Surmeli Z; Cirak Y; Karaca B; Sezgin C; Karabulut B; Uslu R
    J BUON; 2013; 18(2):372-6. PubMed ID: 23818348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cell balance between apoptosis and proliferation in colon cancer and its correlation with prognosis].
    Chen JM; Li WH; Wang JD; Feng YD; Wu JH; Gong JP
    Ai Zheng; 2005 May; 24(5):554-8. PubMed ID: 15890096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.